FDA Pipeline Preview, June 2011 (BioMimetic Therapeutics, Pfizer, D-Pharm, Bayer HealthCare Pharmaceuticals, Mithridion, Cytonet)
Recent FDA action (through May 2011) related to Augment Bone Graft, crizotinib, DP-b99 development program, regorafenib, MCD-386CR, liver cell infusion of donated human liver cells
Recommended for approval
Priority review
Fast-track designations
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Recent Videos
Related Content
